Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
about
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
@ast
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
@en
type
label
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
@ast
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
@en
prefLabel
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
@ast
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
@en
P2860
P356
P1476
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
@en
P2093
Nancy S Reau
Sujit V Janardhan
P2860
P356
10.2147/HMER.S79584
P577
2015-04-16T00:00:00Z